The role of p44/42 activation in tributyltin-induced inhibition of human natural killer cells: Effects of MEK inhibitors

Journal of Applied Toxicology

Volumn 29, Issue 2, 2009, Pages 165-173

  Abraha, Abraham B ^b   Whalen, Margaret M ^a  

^a TENNESSEE STATE UNIVERSITY   (United States)

^b NONE

Author keywords

Lytic function; MAPK; NK cells; p44 42; TBT

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE; TRIBUTYLTIN;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; HUMAN; LYSIS; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; TUMOR CELL;

BUTADIENES; CELL EXTRACTS; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; ENZYME ACTIVATION; ENZYME INHIBITORS; FEMALE; FLAVONOIDS; HUMANS; K562 CELLS; KILLER CELLS, NATURAL; MALE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASE PHOSPHATASES; NITRILES; PHOSPHORYLATION; TIME FACTORS; TRIALKYLTIN COMPOUNDS;

EID: 62849095588     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.1397     Document Type: Article

References (53)

1. Aluoch AO, Whalen MM. 2005. Tributyltin-induced effects on MAP kinases p38 and p44/42 in human natural killer cells. Toxicology 209: 263-277.
2. Aluoch AO, Odman-Ghazi SO, Whalen MM. 2006. Alteration of an essential NK cell signaling pathway by low doses of tributyltin in human natural killer cells. Toxicology 224: 229-237.
3. Baaijens PA. 1986. Health effect screening and biological monitoring for workers in organotin industries. Toxicology analytics of the tributyltins: the present F status. Proceedings of the ORTEPA Workshop Berlin, 15-16 May, ORTEP-Association, Vlissingen-Oost, The Netherlands; 191-208.
4. Camps M, Nichols A, Arkinstall S. 2000. Dual Specificity phosphatases: a gene family for control of MAP kinase functions. FASEB J. 14: 6-16.
5. Chan G, Hanks T, Fisher KD. 2001. Vav-1 regulates NK T cell development and NK cell cytotoxicity. Eur. J. Immunol. 31: 2403-2410.
6. Chang L, Karin M. 2001. Mammalian MAP kinase signaling cascades. Nature 410: 37-40.
7. Chini CCS, Boos MD, Dick CJ, Schoon RA, Leibson PJ. 2000. Regulation of p38 mitogen-activated protein kinase during NK cell activation. Eur. J. Immunol. 30: 2791-2798.
8. Cooper MA, Fehniger TA, Caligiuri MA. 2001. The biology of human natural killer-cell subsets, Trends Immunol. 22: 633-640.
9. Corsini E, Bruccoleri A, Marinovich M, Galli CL. 1996. Endogenous Interleukin-1 α is associated with skin irritation induced by Tributyltin, Toxicol. Appl. Pharmacol. 138: 268-274.
10. Cowley S, Paterson H, Kemp P, Marshall CJ. 1994. Activation of MAP kinase kinase is necessary and sufficient for PC12differentiation and for transformation of NIH 3T3 cells. Cell 77: 841-852.
11. Farooq A, Zhou MM. 2004. Structure and regulation of MAPK phosphatases. Cell. Signal. 16: 769-779.
12. Favata MF, Horiuchi KY, Manos EJ, Daulerio AJ, Stradley DA, Feeser WS, VanDyk DE, Pitts WJ, Earl RA, Hobbs F, Copeland RA, Magolda RL, Scherle PA, Trzaskos JM. 1998. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J. Biol. Chem. 273: 18623-18632.
13. Ghoneum M, Hussein AE, Gill G, Alfred LJ. 1990. Suppression of murine natural killer cell activity by tributyltin: in vivo and in vitro assessment. Environ. Res. 52: 178-186.
14. Hill CS, Treisman R. 1995. Transcriptional regulation by extracellular signals: mechanisms and specificity. Cell 80: 199-211.
15. Hunter T. 1995. Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling. Cell 80: 225-236.
16. Imasato A, Desbois-Mouthon C, Han J, Kai H, Cato AC, Akira S, Li JD. 2002. Inhibition of p38 MAPK by glucocorticoids via induction of MAPK phosphatase-1 enhances nontypeable haemophilus influenzae-induced expression of toll-like receptor 2. J. Biol. Chem. 277: 47444-47450.
17. Kannan K, Falandyz J. 1997. Butyltin residues in sediment, fish, fish-eating birds, harbour porpoise and human tissues from the Polish coast of the Baltic Sea. Mar. Pollut. Bull. 34: 203-207.
18. Kannan K, Tanabe S, Tatsukawa R. 1995a. Occurrence of butyltin residues in certain foodstuffs. Bull. Environ. Contam. Toxicol. 55: 510-516.
19. Kannan K, Tanabe S, Tatsukawa R, Williams RJ. 1995b. Butyltin residues in fish from Australia, Papua New Guinea and the Solomon Islands. Int. J. Environ. Anal. Chem. 61: 263-273.
20. Kannan K, Tanabe S, Iwata H, Tatsukawa R. 1995c. Butyltins in muscle and liver of fish collected from certain Asian and Oceanian countries. Environ. Pollut. 90: 279-290.
21. Kannan K, Villeneuve DL, Blankenship AL, Giesy JP. 1998. Interaction of tributyltin with 3,3′,4,4′,5-pentachlorobiphenyl-induced ethoxyresorufin O-deethylase activity in rat hepatoma cells. J. Toxicol. Enrivon. Health A 55: 373-384.
22. Kannan K, Senthilkumar K, Giesy JP. 1999. Occurrence of butyltin compounds in human blood. Environ. Sci. Technol. 33: 1776-1779.
23. Karpiak VC, Bridges RJ, Flyer CL. 2001. Organotins disrupt components of glutamate homeostasis in rat astrocyte cultures. J. Toxicol. Environ. Health A 63: 273-287.
24. Keyse SM. 2000. Protein phosphatases and the regulation of mitogen-activated protein kinase signalling. Curr. Opin. Cell. Biol. 12: 186-192.
25. Kimbrough RD. 1976. Toxicity and health effects of selected organotins compounds: a review. Environ. Health Perspect. 14: 51-56.
26. Kupper TS. 1989. Mechanism of cutaneous inflammation: interaction between epidermal cytokines, adhesion molecules and leukocytes. Arch. Dermatol. 125: 1406-1412.
27. Lasa M, Abraham SM, Boucheron C, Saklatvala J, Clark AR. 2002. Dexamethasone causes sustained expression of mitogen-activated protein kinase (MAPK) phosphatase 1 and phosphatase-mediated inhibition of MAPK p38. Mol. Cell. Biol. 22: 7802-7811.
28. Laughlin RB, Linden O. 1985. Fate and effects of organotin compounds. Ambio 14: 88-94.
29. Loganathan BG, Kannan K, Owen DA, Sajwan KS. 2000. Butyltin compounds in freshwater ecosystems. In Persistent, Bioaccumulative, and Toxic Chemicals. I Fate and Exposure, Lipnick RL, Hermens J, Jones K, Muir D (eds). American Chemical Society/Oxford University Press: London.
30. Marshall CJ. 1995. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80: 179-185.
31. Moretta L, Biassoni R, Mingari MC, Morerra A. 2002. Natural killer cells: a mystery no more. Scand. J. Immunol. 55: 229-232.
32. Pang L, Sawada T, Decker SJ, Saltiel AR. 1995. Inhibition of MAP kinase kinase blocks the differentiation of PC-12 cells induced by nerve growth factor. J. Biol. Chem. 270: 13585-13588.
33. Payne DW, Rossomando AJ, Martino P, Erickson AK, Her JH, Shabanowitz J, Hunt DF, Weber MJ, Sturgill TW. 1991. Identification of the regulatory phosphorylation sites in pp42/mitogen-activated protein kinase (MAP kinase). EMBO J. 10: 885-892.
34. Roper WL. 1992. Toxicological profile for tin. U.S. Department of Health and Human Services. Agency for Toxic Substances and Disease Registry: USA.
35. Snoeij NJ, Penninks AH, Seinen H. 1987. Biological activity of organotin compounds: an overview. Environ. Res. 44: 335-353.
36. Sturgill TW, Ray LB, Erickson E, Maller JL. 1988. Insulin-stimulated MAP-2 kinase phosphorylates and activated ribosomal protein S6 kinase II. Nature 334: 715-718.
37. Sun H, Charles CH, Lau LF, Tonks NK. 1993. MKP-1 (3CH134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase in vivo. Cell 75: 487-493.
38. Tajima K, Matsumoto N, Ohmori K, Wada H, Ito M, Suzuki K, Yamamoto K. 2004. Augmentation of NK cell-mediated cytotoxicity to tumor cells by inhibitory NK cell receptor blockers. Int. Immunol. 16: 385-393.
39. Tanabe S, Prudente M, Mizuno T, Hasegawa J, Iwata H, Miyazaki N. 1998. Butyltin contamination in marine mammals from north Pacific and Asian coastal waters, Environ. Sci. Technol. 32: 193-198.
40. Trotta R, Puorro KA, Paroli M, Azzoni L, Abebe B, Eisenlohr LC, Perussia B. 1998. Dependence of both spontaneous and antibody-dependent, granule exocytosis-mediated NK cell cytotoxicity on extracellular signal-related kinases. J. Immunol. 161: 6648-6656.
41. Trotta R, Fettucciari K, Azzoni L, Abebe B, Puorro KA, Eisenlohr LC, Perussia, B. 2000. Differential role of p38 and c-Jun N-terminal kinase 1 mitogen-activated protein kinases in NK cell cytotoxicity. J. Immunol. 165: 1782-1789.
42. Tsukazaki M, Satsu H, Mori A, Sugita-Konishi Y, Shimizu M. 2004. Effects of tributyltin on barrier functions in human intestinal Caco-2 cells. Biochem. Biophys. Res. Commun. 315: 991-997.
43. Vivier E, Nunès JA, Vely F. 2004. Natural killer cell signaling pathways. Science 306: 1517-1519.
44. Wei S, Gamero AM, Liu JH, Daulton AA, Valkov NI, Trapani JA, Larner AC, Weber MJ, Djeu JY. 1998. Control of lytic function by mitogen-activated protein kinase/extracellular regulatory kinase 2 (ERK2) in a human natural killer cell line: Identification of perforin and granzyme B mobilization by functional ERK2. J. Exp. Med. 187: 1753-1765.
45. Wei S, Gilvery DL, Corliss BC, Sebti S, Sun J, Straus DB, Liebson PJ, Trapani JA, Hamilton AD, Weber MJ, Djeu JY. 2000. Direct tumor lysis by NK cells uses a Ras-independent mitogen-activated protein kinase signal pathway. J. Immunol. 165: 3811-3819.
46. Whalen MM, Loganathan BG, Kannan K. 1999. Immunotoxicity of environmentally relevant concentrations of butyltins on human natural killer cells in vitro. Environ. Res. 81: 108-116.
47. Whalen MM, Green SA, Loganathan BG. (2002a). Brief butyltin exposure induces irreversible inhibition of the cytotoxic function on human natural killer cells, In vitro. Environ Res. 88, 19-29.
48. Whalen MM, Williams TB, Green SA, Loganathan BG. 2002b. Interleukins 2 and 12 produce recovery of cytotoxic function in tributyltin-exposed human natural killer cells. Environ. Res. 88: 199-209.
49. Wilson S, Dzon L, Reed A, Pruitt M, Whalen MM. 2004. Effects of in vitro exposure to low levels of organotin and carbamate pesticides on human natural killer cell cytotoxic function. Environ. Toxicol. 19: 554-563.
50. World Health Organization. 1990. Tributyltin Compounds. Environmental Health Criteria 116. WHO: Geneva.
51. World Health Organization/Food and Agriculture Organization of the United Nations. 1984. Data sheet on pesticides no. 65: Bis(tributyltin) oxide (VBC/PDS/DS/85.65). WHO: Geneva.
52. Wu J, Lanier LL. 2003. Natural killer cells and cancer. Adv. Cancer Res. 90: 127-156.
53. Yamada S, Fuji Y, Mikami E, Kawamura N, Hayakawa J. 1993. Small-scale survey of organotin compounds in household commodities. J. AOAC Int. 76: 436-441.